DNAG — DNAPrint Genomics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.41m
- $2.43m
Annual income statement for DNAPrint Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2002 December 31st | 2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.185 | 0.71 | 0.786 | 1.28 | 2.43 |
| Cost of Revenue | |||||
| Gross Profit | 0.112 | 0.278 | 0.278 | 0.326 | 0.754 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 2.8 | 6.94 | 4.12 | 5.94 | 11.3 |
| Operating Profit | -2.61 | -6.23 | -3.33 | -4.66 | -8.87 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.11 | -7.79 | -3.73 | -8.71 | -12.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.11 | -7.79 | -3.73 | -8.71 | -12.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.11 | -7.79 | -3.73 | -8.71 | -12.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3.11 | -7.79 | -3.73 | -8.71 | -12.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.138 | -0.312 | -0.106 | -0.093 | -0.034 |
| Dividends per Share |